Timolol maleate ophthalmic recalls

The FDA has published 5 recalls involving Timolol maleate ophthalmic since 2021. The latest was reported on 7 Jun 2023. Most were for sterility. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls5since 2021
Last 12 months0reported
Class I00% of total
Ongoing3latest 7 Jun 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 3 60%Class III 2 40%

Why timolol maleate ophthalmic is recalled

Companies

By year

Ongoing timolol maleate ophthalmic recalls

3 active

All timolol maleate ophthalmic recalls, newest first

5 total

Should you stop taking Timolol maleate ophthalmic?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.